Intuitive Surgical
Nasdaq: ISRG · Health Care · Health Care Equipment · SUNNYVALE, CA
Maker of the da Vinci robotic surgery systems and Ion lung biopsy platform; most revenue is recurring instruments, accessories and service.
Annual results
Click any number to open the SEC filing it came from.
| Line | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.7B | $6.2B | $7.1B | $8.4B | $10.1B |
| Net income | $1.7B | $1.3B | $1.8B | $2.3B | $2.9B |
| EPS — diluted | $4.66 per share | $3.65 per share | $5.03 per share | $6.42 per share | $7.87 per share |
| Cash from operations | $2.1B | $1.5B | $1.8B | $2.4B | $3.0B |
| Free cash flow | $1.7B | $958.4M | $749.6M | $1.3B | $2.5B |
| Total assets | $13.6B | $13.0B | $15.4B | $18.7B | $20.5B |
Recent filings
Members see much more
The full ISRG file, with an AI analyst on it.
- Quarterly statements, segments and IR data
- Valuation, earnings and insider activity
- A research assistant that cites the filing sentence